LivaNova PLC LIVN
$80.62
โผ -0.69% 24H
About
LivaNova is a global medical technology company that develops innovative devices and therapies for cardiac surgery, cardiopulmonary support, and neuromodulation treatments. The company's primary product portfolio includes vagus nerve stimulation therapy for drug-resistant epilepsy and difficult-to-treat depression, aloโฆ
SectorHealthcare
ExchangeNASDAQ
IndustryMedical Devices
CountryUnited Kingdom
Employees3,300
TickerLIVN
Statistics
Market Cap$4.43B
Revenue (TTM)$1.39B
Net Income-$242.5M
Net Margin-17.5%
EPS$1.96
P/E40.79
P/S3.06
P/B3.62
EV/EBITDA15.98
ROE9.5%
Dividend Yieldโ
Price$80.62
Data: Twelve Data ยท Revenue = mcap / P/S